Skip to main content
Log in

Is it time to revise linezolid dose in elderly patients?

  • Letter to the Editor
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Abe S, Chiba K, Cirincione B et al (2009) Population pharmacokinetic analysis of linezolid in patients with infectious disease: application to lower body weight and elderly patients. J Clin Pharmacol 49:1071–1078

    Article  CAS  PubMed  Google Scholar 

  2. Cattaneo D, Gervasoni C, Cozzi V et al (2016) Therapeutic drug management of linezolid: a missed opportunity for clinicians? Int J Antimicrob Agents 48:728–731

    Article  CAS  PubMed  Google Scholar 

  3. Cattaneo D, Alffenaar JW, Neely M (2016) Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones. Expert Opin Drug Metab Toxicol 12:533–544

    Article  CAS  PubMed  Google Scholar 

  4. Pea F, Furlanut M, Cojutti P et al (2010) Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis. Antimicrob Agents Chemother 54:4605–4610

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Cattaneo D, Orlando G, Cozzi V et al (2013) Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with gram-positive infections. Int J Antimicrob Agents 41:586–589

    Article  CAS  PubMed  Google Scholar 

  6. Matsumoto K, Shigemi A, Takeshita A et al (2014) Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients. Int J Antimicrob Agents 44:242–247

    Article  CAS  PubMed  Google Scholar 

  7. Klotz U (2009) Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev 41:67–76

    Article  CAS  PubMed  Google Scholar 

  8. Parameswaran Nair N, Chalmers L, Bereznicki BJ, et al (2017). Adverse drug reaction-related hospitalizations in elderly Australians: a prospective cross-sectional study in two Tasmanian hospitals. Drug Saf. [Epub ahead of print]

  9. Olivier P, Bertrand L, Tubery M et al (2009) Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: a prospective survey. Drugs Aging 26:475–482

    Article  PubMed  Google Scholar 

  10. Laroche ML, Charmes JP, Nouaille Y et al (2007) Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol 63:177–186

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dario Cattaneo.

Ethics declarations

Funding

This is an independent, no-profit, retrospective study carried out as part of the routine management of patients.

Transparency declarations

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tinelli, M., Gervasoni, C., Piazza, M. et al. Is it time to revise linezolid dose in elderly patients?. Eur J Clin Pharmacol 73, 1335–1336 (2017). https://doi.org/10.1007/s00228-017-2303-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-017-2303-6

Navigation